This content is machine translated The Brain and the Motivation to Eat Why is it so hard to lose weight? Obesity is the most common chronic disease in Western societies, with serious metabolic, cardiovascular, and psychosocial consequences. The therapeutic landscape has changed fundamentally: new-generation GLP-1 agonists achieve weight loss that,...… CME-Test
View Post 4 min This content is machine translated GLP1 receptor agonists Positive influence on substance use and addiction GLP1 receptor agonists are gaining increasing recognition, not only for their metabolic benefits in type 2 diabetes, but also for potential effects beyond glycemic control. New experimental evidence suggests that...…
View Post 3 min This content is machine translated Adherence of GLP1-RA Half of patients discontinue treatment within a year GLP1 receptor agonists have revolutionized the treatment of obesity, but their effectiveness depends on long-term and continuous use. However, data from Danish health registries presented at EASD 2025 show that...…
View Post 11 min This content is machine translated Alternative to insulin and GLP1 From the β-cell to the center: the versatile role of amylin Although amylin was discovered decades ago, its importance in everyday clinical practice has long been underestimated. New pharmacological developments are increasingly bringing amylin into the focus of diabetes and obesity...… CME-Test
View Post 11 min This content is machine translated Alternative to insulin and GLP1 From the β-cell to the center: the versatile role of amylin Although amylin was discovered decades ago, its importance in everyday clinical practice has long been underestimated. New pharmacological developments are increasingly bringing amylin into the focus of diabetes and obesity...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 4 min This content is machine translated GLP1-RA therapy Improvement in either weight or HbA1c – but never both Numerous studies show that glucagon-like peptide-1 receptor agonists (GLP1-RA) can significantly reduce the risk of diabetes-related complications and also reduce mortality. Despite their proven efficacy in trial designs, patient response...…
View Post 5 min This content is machine translated Type 2 diabetes Pharmacotherapy can lead to remission Traditionally, the treatment of type 2 diabetes has focused on blood glucose control and the prevention of complications. In the future, these therapeutic approaches could be complemented by another, which,...…
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
